The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival
Authors:
- Engin UlukayaEUEngin Ulukaya
- Arzu YilmaztepeAYArzu Yilmaztepe
- Semra AkgozSASemra Akgoz
- Stig LinderSLStig Linder
- Mehmet KaradagMKMehmet Karadag
- 1 June 2007
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 56 (3) , 399-404
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Detection of epithelial cell death in the body by cytokeratin 18 measurementBiomedicine & Pharmacotherapy, 2005
- Assessment of Apoptosis by Immunohistochemical Markers Compared to Cellular Morphology in Ex Vivo-stressed Colonic MucosaJournal of Histochemistry & Cytochemistry, 2005
- Keratin 8/18 breakdown and reorganization during apoptosisExperimental Cell Research, 2004
- Assessment of apoptosis by M30 immunoreactivity and the correlation with morphological criteria in normal colorectal mucosa, adenomas and carcinomasHistopathology, 2004
- Comparison of immunohistochemistry for activated caspase‐3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC‐3 subcutaneous xenograftsThe Journal of Pathology, 2003
- A Novel High-Through-Put Assay for Screening of Pro-Apoptotic DrugsInvestigational New Drugs, 2002
- Preoperative chemotherapy induces apoptosis in early breast cancerThe Lancet, 1997
- Apoptosis in murine tumors treated with chemotherapy agentsAnti-Cancer Drugs, 1995
- Apoptosis of Lung Cancer Cells Caused by Some Anti-cancer Agents (MMC, CPT-11, ADM) is Inhibited by BCL-2Biochemical and Biophysical Research Communications, 1993
- Mechanisms of cytotoxicity caused by antitumour drugsToxicology Letters, 1992